ManRos Therapeutics is a development-stage biotech company developing new treatments against cystic fibrosis, neurodegenerative diseases, and renal diseases.
Come and meet us
We will be happy to meet you and tell you about our research programs during the following events :
A common research on three pathologies
ManRos Therapeutics develops novel drug candidates acting against severe pathologies, namely cystic fibrosis, neurodegenerative disorders (Alzheimer’s disease and Down syndrome), and some renal diseases (including polycystic kidney disease). Anomalies in phosphorylation are observed in the three pathologies on which ManRos Therapeutics carries out its research: they share common targets and similar mechanisms.
A leading researcher and a pharmaceutical industry expert
ManRos Therapeutics is led by a specialist in cellular and molecular biology, Dr. Laurent Meijer, and a pharmaceutical industry expert, Dr. Philippe de Lavenne.